SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 117 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $95,000 | +5.6% | 10,373 | -19.8% | 0.00% | -33.3% |
| Q3 2015 | $90,000 | -88.9% | 12,933 | -84.4% | 0.00% | -91.2% |
| Q2 2015 | $813,000 | +83.5% | 82,748 | +65.3% | 0.03% | +88.9% |
| Q1 2015 | $443,000 | -8.1% | 50,048 | -9.1% | 0.02% | -10.0% |
| Q4 2014 | $482,000 | +27.2% | 55,061 | 0.0% | 0.02% | +25.0% |
| Q3 2014 | $379,000 | +30.7% | 55,061 | 0.0% | 0.02% | +33.3% |
| Q2 2014 | $290,000 | +54.3% | 55,061 | +33.1% | 0.01% | +50.0% |
| Q1 2014 | $188,000 | -11.7% | 41,370 | -2.0% | 0.01% | -20.0% |
| Q4 2013 | $213,000 | +21.0% | 42,200 | +21.6% | 0.01% | +11.1% |
| Q3 2013 | $176,000 | +55.8% | 34,700 | +52.2% | 0.01% | +80.0% |
| Q2 2013 | $113,000 | – | 22,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |